Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5
datasets available to search
ShareScore release 0.9.0
Dataset results
5 results for “lumpy skin disease”
Synoptic table for surveillance scenarios for lumpy skin disease
<p>The Standing Group of Experts on lumpy skin disease (LSD) for South-East Europe under the GF-TADs umbrella recommended that all countries in South-East Europe, affected or at risk for LSD, should collaborate within the GF-TADs to draft a regional roadmap on an LSD exit strategy from 2018 onwards. This recommendation has triggered a mandate to EFSA in which it is asked to assess the effectiveness of different surveillance systems with different objectives, i.e. early detection or demonstration of freedom from disease, in the following contexts:</p> <p>(a) in areas or countries at risk of LSD, where no LSD outbreaks have occurred and LSD vaccination was never carried out;</p> <p>(b) in areas or countries at risk of LSD, where no LSD outbreaks have occurred and where LSD vaccination is carried out;</p> <p>(c) in areas where no LSD outbreaks have occurred and LSD preventive vaccination was carried out, and then stopped;</p> <p>(d) in areas where LSD outbreaks have been confirmed, and vaccination is stopped.</p> <p>For planning surveillance several elements should be considered: the objectives and related design prevalence, the epidemiological situation, the immunological status of the host population, the geographical area and the season, the type of surveillance (active or passive), the diagnostic methods including clinical detection (considered the most effective method for early detection of LSD), the target population, the sample size and frequency. Here a synoptic table is presented where each of these elements are discussed for each of the four scenarios given above.</p>
Synoptic table for surveillance scenarios for lumpy skin disease
<p>The Standing Group of Experts on lumpy skin disease (LSD) for South-East Europe under the GF-TADs umbrella recommended that all countries in South-East Europe, affected or at risk for LSD, should collaborate within the GF-TADs to draft a regional roadmap on an LSD exit strategy from 2018 onwards. This recommendation has triggered a mandate to EFSA in which it is asked to assess the effectiveness of different surveillance systems with different objectives, i.e. early detection or demonstration of freedom from disease, in the following contexts:</p> <p>(a) in areas or countries at risk of LSD, where no LSD outbreaks have occurred and LSD vaccination was never carried out;</p> <p>(b) in areas or countries at risk of LSD, where no LSD outbreaks have occurred and where LSD vaccination is carried out;</p> <p>(c) in areas where no LSD outbreaks have occurred and LSD preventive vaccination was carried out, and then stopped;</p> <p>(d) in areas where LSD outbreaks have been confirmed, and vaccination is stopped.</p> <p>For planning surveillance several elements should be considered: the objectives and related design prevalence, the epidemiological situation, the immunological status of the host population, the geographical area and the season, the type of surveillance (active or passive), the diagnostic methods including clinical detection (considered the most effective method for early detection of LSD), the target population, the sample size and frequency. Here a synoptic table is presented where each of these elements are discussed for each of the four scenarios given above.</p>
Data for Galaxy training in assembly of Lumpy Skin Disease Virus Genome
<p>This upload was to support a Galaxy tutorial on the Lumpy Skin Disease virus genome prepared by the Defend2020 project. To access the data deposited in Genbank and the Sequence Read Archive please refer to the following deposits.</p> <p>The LSDV isolate Kubash/KAZ/16 sequence has been deposited in GenBank under accession number <a href="https://www.ncbi.nlm.nih.gov/nuccore/MN642592">MN642592</a>, and raw data have been submitted to the SRA under BioProject number <a href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA587601/">PRJNA587601</a>.</p>
Advanced Iterative Model for Lumpy Skin Disease Prediction Using Fine-grained Feature Fusion and Adaptive Transfer Learning
Open the record for dataset details and reuse information.
The Effect of Vaccination with Live Attenuated Neethling Lumpy Skin Disease Vaccine on Milk Production and Mortality—an Analysis of 77 Dairy Farms in Israel
<p>This is the R script, full data and data for figures 3 and 4 of the article "The Effect of Vaccination with Live Attenuated Neethling Lumpy Skin Disease Vaccine on Milk Production and Mortality—an Analysis of 77 Dairy Farms in Israel"</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.